Cannabinoid Drugs Market 2027 By Product Type, Application, Compound | The Insight Partners

Cannabinoid Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Phytocannabinoids, Endocannabinoids, Synthetics); Application (Medical, Recreational); Compound (THC-dominant, CBD-Dominant, Balanced THC and CBD)

Report Code: TIPRE00015274 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Cannabinoid Drugs are natural occurring recreational drugs used to treat anorexia, chronic pain, and nausea & vomiting. The cannabinoid is used for a group of drugs that are structurally related to tetrahydro cannabinoids. It is manufactured by pharma companies to treat different indications, such as multiple chronic & acute migraine, sclerosis, seizures, rheumatoid arthritis, etc.

MARKET DYNAMICS

The Cannabinoid Drugs market is expected to grow significantly in the coming years, due to Rising demand for cannabinoid drugs for treating chronic pain in different indications. Moreover, healthcare expenditure in field of dermatology supported by FDA approvals anticipated to influence the end-user of Cannabinoid Drugs .

MARKET SCOPE

The "Cannabinoid Drugs Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cannabinoid Drugs market with detailed market segmentation by, product type , application and compound. The Cannabinoid Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Cannabinoid Drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Cannabinoid Drugs market is segmented on the basis of product type , application and compound. Based on product type, the market is segmented into Phyto cannabinoids, Endocannabinoids, Synthetics. On the basis of application, the market is categorized as Medical, Recreational. On the basis of compound, the market is categorized as THC-dominant , CBD-Dominant, Balanced THC and CBD.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cannabinoid Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cannabinoid Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cannabinoid drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cannabinoid Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Cannabinoid Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cannabinoid Drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Cannabinoid Drugs in the global market. Below mentioned is the list of few companies engaged in the Cannabinoid Drugs market.

The report also includes the profiles of key players in Cannabinoid Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Canopy Growth Corporation
  •   Aurora Cannabis Inc.
  •   Tikun Olam
  •   Cannabis Science Inc.
  •   Aphria Inc.
  •   Maricann Group Inc.
  •   Tilray Inc.
  •   VIVO Cannabis Inc.
  •   Medical Marijuana, Inc.
  •   STENOCARE

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cannabinoid Drugs Market - By Product Type
1.3.2 Cannabinoid Drugs Market - By Application
1.3.3 Cannabinoid Drugs Market - By Compound
1.3.4 Cannabinoid Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANNABINOID DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANNABINOID DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANNABINOID DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CANNABINOID DRUGS - GLOBAL MARKET OVERVIEW
6.2. CANNABINOID DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANNABINOID DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHYTOCANNABINOIDS
7.3.1. Overview
7.3.2. Phytocannabinoids Market Forecast and Analysis
7.4. ENDOCANNABINOIDS
7.4.1. Overview
7.4.2. Endocannabinoids Market Forecast and Analysis
7.5. SYNTHETICS
7.5.1. Overview
7.5.2. Synthetics Market Forecast and Analysis
8. CANNABINOID DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MEDICAL
8.3.1. Overview
8.3.2. Medical Market Forecast and Analysis
8.4. RECREATIONAL
8.4.1. Overview
8.4.2. Recreational Market Forecast and Analysis
9. CANNABINOID DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - COMPOUND
9.1. OVERVIEW
9.2. COMPOUND MARKET FORECASTS AND ANALYSIS
9.3. THC-DOMINANT
9.3.1. Overview
9.3.2. THC-dominant Market Forecast and Analysis
9.4. CBD-DOMINANT
9.4.1. Overview
9.4.2. CBD-Dominant Market Forecast and Analysis
9.5. BALANCED THC AND CBD
9.5.1. Overview
9.5.2. Balanced THC and CBD Market Forecast and Analysis
10. CANNABINOID DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cannabinoid Drugs Market Overview
10.1.2 North America Cannabinoid Drugs Market Forecasts and Analysis
10.1.3 North America Cannabinoid Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Cannabinoid Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Cannabinoid Drugs Market Forecasts and Analysis - By Compound
10.1.6 North America Cannabinoid Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cannabinoid Drugs Market
10.1.6.1.1 United States Cannabinoid Drugs Market by Product Type
10.1.6.1.2 United States Cannabinoid Drugs Market by Application
10.1.6.1.3 United States Cannabinoid Drugs Market by Compound
10.1.6.2 Canada Cannabinoid Drugs Market
10.1.6.2.1 Canada Cannabinoid Drugs Market by Product Type
10.1.6.2.2 Canada Cannabinoid Drugs Market by Application
10.1.6.2.3 Canada Cannabinoid Drugs Market by Compound
10.1.6.3 Mexico Cannabinoid Drugs Market
10.1.6.3.1 Mexico Cannabinoid Drugs Market by Product Type
10.1.6.3.2 Mexico Cannabinoid Drugs Market by Application
10.1.6.3.3 Mexico Cannabinoid Drugs Market by Compound
10.2. EUROPE
10.2.1 Europe Cannabinoid Drugs Market Overview
10.2.2 Europe Cannabinoid Drugs Market Forecasts and Analysis
10.2.3 Europe Cannabinoid Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Cannabinoid Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Cannabinoid Drugs Market Forecasts and Analysis - By Compound
10.2.6 Europe Cannabinoid Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cannabinoid Drugs Market
10.2.6.1.1 Germany Cannabinoid Drugs Market by Product Type
10.2.6.1.2 Germany Cannabinoid Drugs Market by Application
10.2.6.1.3 Germany Cannabinoid Drugs Market by Compound
10.2.6.2 France Cannabinoid Drugs Market
10.2.6.2.1 France Cannabinoid Drugs Market by Product Type
10.2.6.2.2 France Cannabinoid Drugs Market by Application
10.2.6.2.3 France Cannabinoid Drugs Market by Compound
10.2.6.3 Italy Cannabinoid Drugs Market
10.2.6.3.1 Italy Cannabinoid Drugs Market by Product Type
10.2.6.3.2 Italy Cannabinoid Drugs Market by Application
10.2.6.3.3 Italy Cannabinoid Drugs Market by Compound
10.2.6.4 Spain Cannabinoid Drugs Market
10.2.6.4.1 Spain Cannabinoid Drugs Market by Product Type
10.2.6.4.2 Spain Cannabinoid Drugs Market by Application
10.2.6.4.3 Spain Cannabinoid Drugs Market by Compound
10.2.6.5 United Kingdom Cannabinoid Drugs Market
10.2.6.5.1 United Kingdom Cannabinoid Drugs Market by Product Type
10.2.6.5.2 United Kingdom Cannabinoid Drugs Market by Application
10.2.6.5.3 United Kingdom Cannabinoid Drugs Market by Compound
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cannabinoid Drugs Market Overview
10.3.2 Asia-Pacific Cannabinoid Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Cannabinoid Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Cannabinoid Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Cannabinoid Drugs Market Forecasts and Analysis - By Compound
10.3.6 Asia-Pacific Cannabinoid Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cannabinoid Drugs Market
10.3.6.1.1 Australia Cannabinoid Drugs Market by Product Type
10.3.6.1.2 Australia Cannabinoid Drugs Market by Application
10.3.6.1.3 Australia Cannabinoid Drugs Market by Compound
10.3.6.2 China Cannabinoid Drugs Market
10.3.6.2.1 China Cannabinoid Drugs Market by Product Type
10.3.6.2.2 China Cannabinoid Drugs Market by Application
10.3.6.2.3 China Cannabinoid Drugs Market by Compound
10.3.6.3 India Cannabinoid Drugs Market
10.3.6.3.1 India Cannabinoid Drugs Market by Product Type
10.3.6.3.2 India Cannabinoid Drugs Market by Application
10.3.6.3.3 India Cannabinoid Drugs Market by Compound
10.3.6.4 Japan Cannabinoid Drugs Market
10.3.6.4.1 Japan Cannabinoid Drugs Market by Product Type
10.3.6.4.2 Japan Cannabinoid Drugs Market by Application
10.3.6.4.3 Japan Cannabinoid Drugs Market by Compound
10.3.6.5 South Korea Cannabinoid Drugs Market
10.3.6.5.1 South Korea Cannabinoid Drugs Market by Product Type
10.3.6.5.2 South Korea Cannabinoid Drugs Market by Application
10.3.6.5.3 South Korea Cannabinoid Drugs Market by Compound
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cannabinoid Drugs Market Overview
10.4.2 Middle East and Africa Cannabinoid Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Cannabinoid Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Cannabinoid Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Cannabinoid Drugs Market Forecasts and Analysis - By Compound
10.4.6 Middle East and Africa Cannabinoid Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cannabinoid Drugs Market
10.4.6.1.1 South Africa Cannabinoid Drugs Market by Product Type
10.4.6.1.2 South Africa Cannabinoid Drugs Market by Application
10.4.6.1.3 South Africa Cannabinoid Drugs Market by Compound
10.4.6.2 Saudi Arabia Cannabinoid Drugs Market
10.4.6.2.1 Saudi Arabia Cannabinoid Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Cannabinoid Drugs Market by Application
10.4.6.2.3 Saudi Arabia Cannabinoid Drugs Market by Compound
10.4.6.3 U.A.E Cannabinoid Drugs Market
10.4.6.3.1 U.A.E Cannabinoid Drugs Market by Product Type
10.4.6.3.2 U.A.E Cannabinoid Drugs Market by Application
10.4.6.3.3 U.A.E Cannabinoid Drugs Market by Compound
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cannabinoid Drugs Market Overview
10.5.2 South and Central America Cannabinoid Drugs Market Forecasts and Analysis
10.5.3 South and Central America Cannabinoid Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Cannabinoid Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Cannabinoid Drugs Market Forecasts and Analysis - By Compound
10.5.6 South and Central America Cannabinoid Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cannabinoid Drugs Market
10.5.6.1.1 Brazil Cannabinoid Drugs Market by Product Type
10.5.6.1.2 Brazil Cannabinoid Drugs Market by Application
10.5.6.1.3 Brazil Cannabinoid Drugs Market by Compound
10.5.6.2 Argentina Cannabinoid Drugs Market
10.5.6.2.1 Argentina Cannabinoid Drugs Market by Product Type
10.5.6.2.2 Argentina Cannabinoid Drugs Market by Application
10.5.6.2.3 Argentina Cannabinoid Drugs Market by Compound
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANNABINOID DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CANNABINOID DRUGS MARKET, KEY COMPANY PROFILES
13.1. CANOPY GROWTH CORPORATION
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AURORA CANNABIS INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TIKUN OLAM
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CANNABIS SCIENCE INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. APHRIA INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MARICANN GROUP INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. TILRAY INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. VIVO CANNABIS INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MEDICAL MARIJUANA, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. STENOCARE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Canopy Growth Corporation
2. Aurora Cannabis Inc.
3. Tikun Olam
4. Cannabis Science Inc.
5. Aphria Inc.
6. Maricann Group Inc.
7. Tilray Inc.
8. VIVO Cannabis Inc.
9. Medical Marijuana, Inc.
10. STENOCARE
TIPRE00015274
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking